Skip to main content

Table 1 Baseline clinical characteristics of patients with cervical tuberculous lymphadenitis

From: Characteristics of residual lymph nodes after six months of antituberculous therapy in HIV-negative individuals with cervical tuberculous lymphadenitis

 All patients (n = 165)
Gender (male)40 (24.2%)
Age (years, mean ± SD)42.5 ± 16.1
Previous history of TB13 (7.9%)
Comorbidity35 (21.2%)
 Cardiovascular diseases25 (15.2%)
 Diabetes mellitus11 (6.7%)
 Chronic renal diseases7 (4.2%)
 Hematologic malignancy4 (2.4%)
Duration of lymphadenopathy (months, mean ± SD)8.2 ± 29.8
Location of cervical lymph node
 Bilateral14 (8.5%)
 Left side59 (35.8%)
 Right side92 (55.8%)
Largest size of the lymph node (mm, mean ± SD)33.1 ± 24.5
Results of the initial diagnostic work-up
 Compatible with TB on CT scan, n/Na123/143 (86.0%)
 AFB positive, n/Na20/96 (20.8%)
 TB culture positive, n/Na36/80 (45.0%)
 TB PCR positive, n/Na121/158 (76.6%)
 Histologic findings indicative of TB136/164 (82.9%)
Paradoxical reaction during treatment38 (23.0%)
CT scan after 6 months of antituberculous therapy157 (95.2%)
 Residual lymph nodeb35 (22.3%)
Duration of antituberculous therapy (months, mean ± SD)7.9 ± 4.4
  1. aNo. of patients tested
  2. bResidual lymph node was defined as a lymph node larger than 10 mm in diameter with central necrosis, peripheral rim enhancement, or perinodal infiltration on computed tomography scan